Mizuho lowered the firm’s price target on Doximity (DOCS) to $60 from $65 and keeps a Neutral rating on the shares. The firm believes investors may initially react negatively to the company’s initial fiscal 2026 guidance, which came in below the Street at midpoints for revenues and EBITDA.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Morning Movers: Charter to combine with Cox Communication
- Doximity price target lowered to $65 from $83 at Raymond James
- Doximity’s Strong Performance and Strategic Positioning Justify Buy Rating Despite Conservative Revenue Guidance
- Doximity price target lowered to $50 from $71 at Canaccord
- Doximity: Strong Performance Amidst Cautious Outlook Warrants Hold Rating